מכפיל P/S עתידי: BrainsWay Limited (BWAY)
The expected revenue multiple visualizes the speed of revenue revaluation for BrainsWay Ltd. (BWAY), with 3.20 indicating the current level. The asset serves as a defensive tool due to its independence from macroeconomic factors. However, resilience is limited by insurance coverage complexities and competition from pharmaceuticals. The operational stability of TMS systems also depends on adherence to strict high-tech transportation regulations for delivering equipment to medical centers.
brainsway.com (BWAY) - פילוחי מדדים ודוחות פיננסיים
The forward P/S ratio relates current market capitalization to expected revenue for the coming year, allowing for an assessment of the degree of investor optimism priced in. By analyzing the forward P/S trajectory, one can determine the extent to which the market overvalues the potential of BrainsWay Ltd. (BWAY) magnetic brain stimulation technology in treating depression, in order to timely recognize the risk of a correction should sales forecasts remain unmet.
